COVID-19 Vaccine Hesitancy Among Nurses

The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses. The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination. The purpose of the study is also wants to build a basis for future research and public support in vaccine decision-making, as well as to enhance the promotion of vaccine policy and enhance the resilience of the whole population during the pandemic ear.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Behavior Coronaviridae Infections Coronavirus Infections Health Behavior Infections Lung Diseases Nidovirales Infections Nurses Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Treatment Adherence and Compliance Treatment Refusal Vaccination Vaccination Hesitancy Vaccination Refusal Vaccine Hesitancy Virus Diseases

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Nursing, National Taiwan University

Taipei, Taiwan

About this study

A cross-sectional study based on convenience samples. The investigators recruit nurses and the general public to respond to structured self-filling electronic questionnaires by using an electronic data collection system. The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items. Convenience sampling was applied to estimate the sample size according to the number of nurses in each county. It is planned to collect a total of 4258 responses by the end of the study. The study instrument is the 5C psychological antecedents of vaccination, which includes Confidence, Complacency, Constraints, Calculation, and Collective Responsibility.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

[Nurses]

Inclusion criteria

Male and female participants must be ≥ 20 years at the time of informed consent.
Male and female participants have verification of registered nurse license.

Exclusion criteria

Male and female participants be>80 years at the time of informed consent.

[General publics]

Inclusion criteria

Male and female participants must be ≥ 20 years at the time of informed consent.
Male and female participants have reading abilities above the intermediate level.

Exclusion criteria

Male and female participants be>80 years at the time of informed consent.

Treatment and study plan

questionnaires

Other

The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.

Primary outcomes

The correlation of intention to receive COVID-19 vaccine and 5C psychological antecedents (5C scale) among nurses and general publics.

Time frame: The questionnaire length around 10 minutes.

The 5C scale measures the psychological antecedents of vaccination, using 15 item tools including 5 domains (confidence, complacency, constraints, calculation, and collective responsibility). Each domain was assessed by 3 rating items on a 7-point scale (1=strongly disagree; 7=strongly agree). The mean scores of items under each domain were computed, with a higher average score indicating stronger agreement of the corresponding domain.

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Jan 28, 2022
Registry last updated: Jul 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed